Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #16
    Originally posted by bertgold View Post
    It occurs to me that you probably centrifuge and aspirate the Ethanol. That will not work for the throughputs we are using.

    Yes, the CleanSeq at $ 20,000 per liter (appoximately) is far more expensive than the big dye per reaction.
    Actually we just do inverted spins to remove the ethanol. However we do use a 6K RPM plate centrifuge for the precipitation spin. The protocol is nothing special. The only changes that were critical were reducing the sodium acetate concentration 1000x (probably no different than adding only ethanol to the precipitation) and using somewhat less than 2 volumes of ethanol. The former aids electrokinetic injection of product and the latter helps with signal droop.

    But I admit this may not scale well. To tell you the truth, Sanger sequencing is so obviously trailing edge at this point, I just can't find the motivation to continue to tinker with it. At this point I just "put out fires" but otherwise leave the technique as is.

    --
    Phillip

    Comment

    • pmiguel
      Senior Member
      • Aug 2008
      • 2328

      #17
      Originally posted by bertgold View Post
      I am using 0.05 microliters big dye per well in 384 well plate.
      Ah, up-thread you wrote:

      I am using 2 microliter reactions for big dye in a 384 well plate

      So I presumed you meant 2ul of Big Dye (1/4th) reactions. But you must have meant 2ul total volume reactions and 1/160th reactions. I don't know what you are paying in CleanSeq, but you say it is more than the 4 cents you pay in Big Dye. I am going to guess that it is at least 6 cents. So you still have polymer, capillary and service contract costs. Even with preferential government pricing on your instrument service contracts I guess you are looking at near $20K/year per sequencer. Call it $50/ day or another $0.04/reaction.

      Well, to spare everyone the rest of the blow-by-blow I think it is safe to say that you are looking at costs of at least $0.20/reaction. So, let's call this $0.20 per 1E-03 bases or $200/megabase of raw sequence. This puts you at least 1 order of magnitude above the cost of a GS-FLX or Ion Torrent data set of the same size. And that means an Illumina data set of the same size would run you 2 orders of magnitude less.

      Which is not to say that Sanger sequence will not get you the most bang for your particular buck. But given the level of optimization you have gone to for Sanger, my guess is that you would have little difficulty re-tooling for a Next Generation protocol that would drop your costs 10x, if not more. I hasten to add that I am not saying it would be easy, but for you I doubt it would be hard. Although change is frequently painful, you might as well get used to the current sequencing paradigms, if you have a choice.


      --
      Phillip

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Yesterday, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      71 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...